Search results
Syndax reports encouraging results from AML treatment trials By Investing.com
Investing.com· 2 days agoSyndax Pharmaceuticals (NASDAQ: NASDAQ:SNDX), a clinical stage biopharmaceutical company, has...
Cranbury Pharmaceuticals Receives FDA Approval for First Generic Version of Emflaza Oral Suspension
New Jersey Business Magazine· 3 days agoCranbury Pharmaceuticals, a wholly-owned subsidiary of Tris Pharma, today announced the U.S. Food...
Vertex says Casgevy benefit extends to nearly five years in sickle cell disease
Clinical Trials Arena via Yahoo Finance· 2 days agoVertex Pharmaceuticals has reported long-term data for its gene therapy Casgevy (exa-cel) in...
The 3 Best Healthcare Stocks to Buy in June 2024
InvestorPlace· 9 hours agoSeveral demand drivers will benefit the best healthcare stocks to buy across the entire value chain. First, let’s highlight the major healthcare...
Counterfeit-Busting SHOP SAFE Act Heads to Congress
Sourcing Journal via Yahoo News· 1 day agoFakes aren’t just an issue for consumers; they are often produced through unregulated...brand protection Jennifer Hanks called consumer safety “a...
Rigel Announces Five Presentations at the EHA2024 Hybrid Congress
WKRN Nashville· 2 days ago(Nasdaq: RIGL) today announced one oral and four poster presentations at the European Hematology Association (EHA) 2024 Hybrid Congress in Madrid, Spain being held June 13 ...
NASA administrator describes future projects, partnerships in space
Fox News via Yahoo News· 3 days agoNASA administrator Bill Nelson discusses the American space program's history and future, from space...
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at...
Digital Journal· 1 day agoLAVAL, QC / ACCESSWIRE / June 14, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), a global diversified pharmaceutical company enriching lives through a relentless ...
Trump claims ‘great unity’ after talks with congressional GOP
Pennsylvania Capital-Star via Yahoo News· 2 days agoThe positive reception from GOP leaders showed Trump’s standing in the party improved since the Jan....
McKinsey Boss’s Next Big Consulting Project: His Own Firm
The Wall Street Journal· 4 days agoMcKinsey said in 2021 it would pay $641 million in settlements for its work with OxyContin maker...